|
1
|
Chen X, Wang T, Yang D, Wang J, Li X, He
Z, Chen F, Che X and Song X: Expression of the IAP protein family
acts cooperatively to predict prognosis in human bladder cancer
patients. Oncol Lett. 5:1278–1284. 2013.PubMed/NCBI
|
|
2
|
Liu C, Wu X, Luo C, Hu Z, Yin Z, He Y, Du
H, Zhang W, Jiang Q and Lin Y: Antisense oligonucleotide targeting
Livin induces apoptosis of human bladder cancer cell via a
mechanism involving caspase 3. J Exp Clin Cancer Res. 29:632010.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Xi RC, Sheng YR, Chen WH, Sheng L, Gang
JJ, Tong Z, Shan Z, Ying GH and Dong LC: Expression of survivin and
livin predicts early recurrence in non-muscle invasive bladder
cancer. J Surg Oncol. 107:550–554. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang D, Jiang Y, Ouyang S, Liu B, Zhu T,
Niu H and Tian Y: Inhibitory effect of valproic acid on bladder
cancer in combination with chemotherapeutic agents in vitro and in
vivo. Oncol Lett. 6:1492–1498. 2013.PubMed/NCBI
|
|
5
|
Yang D, Song X, Zhang J, Ye L, Wang S, Che
X, Wang J, Zhang Z and Wang L: Suppression of livin gene expression
by siRNA leads to growth inhibition and apoptosis induction in
human bladder cancer T24 cells. Biosci Biotechnol Biochem.
74:1039–1044. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kubowicz P, Żelaszczyk D and Pekala E:
RNAi in clinical studies. Curr Med Chem. 20:1801–1816. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kang XL, Geng ZH, Lu XX, Wei C, Wang JG,
Wang SZ, Ma S, Liu HX, Xu GY, Zhang HW and Wang GY: Detecting
multi-drug resistance of bladder cancer for the intravesical
chemotherapy. Zhonghua Wai Ke Za Zhi. 42:285–287. 2004.PubMed/NCBI
|
|
8
|
Guo H, Gao YT, Zhang Q, Jing L, Liu T, Shi
WX, Zhai DK, Jing X and Du Z: Expression and clinical significance
of livin protein in hepatocellular carcinoma. Dis Markers.
35:489–496. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chung CY, Park YL, Kim N, Park HC, Park
HB, Myung DS, Kim JS, Cho SB, Lee WS and Joo YE: Expression and
prognostic significance of Livin in gastric cancer. Oncol Rep.
30:2520–2528. 2013.PubMed/NCBI
|
|
10
|
Xu M, Xia LP, Fan LJ, Xue JL, Shao WW and
Xu D: Livin and caspase-3 expression are negatively correlated in
cervical squamous cell cancer. Eur J Gynaecol Oncol. 34:152–155.
2013.PubMed/NCBI
|
|
11
|
Ding ZY, Liu GH, Olsson B and Sun XF:
Upregulation of the antiapoptotic factor Livin contributes to
cisplatin resistance in colon cancer cells. Tumour Biol.
34:683–693. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sun JG, Liao RX, Zhang SX, Duan YZ, Zhuo
WL, Wang XX, Wang ZX, Li DZ and Chen ZT: Role of inhibitor of
apoptosis protein Livin in radiation resistance in nonsmall cell
lung cancer. Cancer Biother Radiopharm. 26:585–592. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chung CY, Park YL, Kim N, Park HC, Park
HB, Myung DS, Kim JS, Cho SB, Lee WS and Joo YE: Expression and
prognostic significance of Livin in gastric cancer. Oncol Rep.
30:2520–2528. 2013.PubMed/NCBI
|
|
14
|
Hannon GJ: RNA interference. Nature.
418:244–251. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhou W, Chen H, Hong X, Niu X and Lu Q:
Knockdown of DNA methyltransferase-1 inhibits proliferation and
derepresses tumor suppressor genes in myeloma cells. Oncol Lett.
8:2130–2134. 2014.PubMed/NCBI
|
|
16
|
Płuciennik E, Nowakowska M, Stȩpien A,
Wołkowicz M, Stawiński A, Różański W, Lipiński M and Bednarek AK:
Alterating expression levels of WWOX tumor suppressor and
cancer-related genes in patients with bladder cancer. Oncol Lett.
8:2291–2297. 2014.PubMed/NCBI
|
